REOPRO Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: REOPRO

Patents:	203
Applicants:	1
BLAs:	1
Recent Clinical Trials:	See clinical trials for REOPRO
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for REOPRO

Recent Clinical Trials for REOPRO

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Janssen Services, LLC	Phase 2
St. Louis University	Phase 2
SOS Attaque Cérébrale	Phase 4

See all REOPRO clinical trials

Recent Litigation for REOPRO

Identify key patents and potential future biosimilar entrants

District Court Litigation

Case Name	Date
ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD.	2016-12-07
Boston Scientific Corporation v. Johnson and Johnson Inc.	2007-06-01
Abbott Laboratories v. Johnson and Johnson Inc.	2007-05-15

See all REOPRO litigation

PTAB Litigation

Petitioner	Date
Instrumentation Laboratory Company	2019-04-24
Instrumentation Laboratory Company	2019-02-21
	2017-11-30

See all REOPRO litigation

Patent Text Search: US Patents for REOPRO

These patents were identified by searching patent claims

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Centocor Inc	REOPRO	abciximab	INJECTABLE; INJECTION	103575	001	1994-12-22	Start Trial	HemoSonics LLC (Charlottesville, VA)	2031-02-15	RX		search
Centocor Inc	REOPRO	abciximab	INJECTABLE; INJECTION	103575	001	1994-12-22	Start Trial	INSPIREMD, LTD. (IL)	2025-05-24	RX		search
Centocor Inc	REOPRO	abciximab	INJECTABLE; INJECTION	103575	001	1994-12-22	Start Trial	LOCAL PHARMA, INC. (Las Vegas, NV)	2028-01-09	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for REOPRO

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	101028538	Start Trial
South Korea	100826574	Start Trial
Germany	602007008855	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.